Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents-Reference-Cited by-同舟云学术

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Published:2019-11-21 Issue:21 Volume:381 Page:2009-2019
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Biswal Shibadas¹,Reynales Humberto¹,Saez-Llorens Xavier¹,Lopez Pio¹,Borja-Tabora Charissa¹,Kosalaraksa Pope¹,Sirivichayakul Chukiat¹,Watanaveeradej Veerachai¹,Rivera Luis¹,Espinoza Felix¹,Fernando LakKumar¹,Dietze Reynaldo¹,Luz Kleber¹,Venâncio da Cunha Rivaldo¹,Jimeno José¹,López-Medina Eduardo¹,Borkowski Astrid¹,Brose Manja¹,Rauscher Martina¹,LeFevre Inge¹,Bizjajeva Svetlana¹,Bravo Lulu¹,Wallace Derek¹

Affiliation:

1. From Takeda Vaccines, Singapore (S. Biswal); Centro de Atención e Investigación Médica, Bogota (H.R.), and Centro de Estudios en Infectología Pediatrica, Centro Médico Imbanaco and Department of Pediatrics, Universidad del Valle, Cali (P.L., E.L.-M.) — both in Colombia; the Department of Infectious Diseases at Hospital del Niño Dr. José Renán Esquivel, Sistema Nacional de Investigación at Secretaria Nacional de Ciencia y Tecnologia (SENACYT), Centro de Vacunación Internacional (Cevaxin), Panama City,...

Funder

Takeda Vaccines Inc., MA, USA

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1903869

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dengue Fever Epidemics and the Prospect of Vaccines: A Systematic Review and Meta-Analysis Using Clinical Trials in Children;Diseases;2024-02-06

2. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial;The Lancet Global Health;2024-02

3. Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial;The Lancet Infectious Diseases;2024-02

4. Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults;New England Journal of Medicine;2024-02-01

5. Three Dengue Vaccines — What Now?;New England Journal of Medicine;2024-02-01